Quantcast

Latest ovarian cancer Stories

2014-09-06 23:01:12

New Translational Research Ovarian Cancer Dream Team to Tackle Deadliest Gynecologic Cancer Phoenix, AZ (PRWEB) September 06, 2014 A groundbreaking collaboration is underway among many of the nation’s ovarian cancer organizations. In partnership with Stand Up To Cancer, a new Ovarian Cancer Dream Team will kick off this year, dedicated to piloting leading-edge, ovarian cancer research that will help patients and save lives. The Dream Team effort is led by Ovarian Cancer Research Fund,...

2014-09-04 08:30:41

International movement hosts 170 awareness events throughout September for GYN Cancer Awareness Month WASHINGTON, Sept. 4, 2014 /PRNewswire/ -- Globe-athon to End Women's Cancers kicked-off today with the announcement of 170 events occurring in 70 countries throughout September to raise awareness of silent, yet deadly below the belt cancers. In its second year, Globe-athon awareness events, screenings and educational seminars will occur worldwide during GYN Cancer Awareness Month to...

2014-09-03 23:04:20

The Worthy Collection Partners with National Ovarian Cancer Alliance on Unique Fashion-for-Philanthropy Campaign New York, NY (PRWEB) September 03, 2014 -- Fashion-for-Fundraising Campaign Unites Apparel with Philanthropy to Support Ovarian Cancer, Help Save Women’s Lives -- This year, an estimated 22,000 women in the U.S. will get ovarian cancer, according to a just-published study by the American Cancer Society. Of these, two-thirds may die[1]. To honor National Ovarian Cancer...

2014-09-03 16:29:18

In the news release, Oncolytics Biotech® Inc. Announces Completion of Patient Enrollment in U.S. Randomized Phase 2 Ovarian Cancer Study, issued 03-Sep-2014 by Oncolytics Biotech Inc. over CNW, we are advised by the company that at the end of the fourth paragraph, "150 patients" should read "110 patients". The complete, corrected release follows: Oncolytics Biotech® Inc. Announces Completion of Patient Enrollment in U.S. Randomized Phase 2 Ovarian Cancer Study CALGARY,...

2014-09-03 08:35:05

LMOCF continues to fund research efforts and provides four ways to join the fight during National Ovarian Cancer Awareness Month NEW YORK, Sept. 3, 2014 /PRNewswire/ -- The Laura Mercier Ovarian Cancer Fund (LMOCF) commemorates National Ovarian Cancer Awareness Month by releasing new fundraising products and encouraging others to get involved with the cause. Ovarian cancer is the leading cause of death among gynecological cancers and fifth leading cause of death among women in the U.S.*...

2014-09-03 08:32:29

CALGARY, Sept. 3, 2014 /PRNewswire/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) today announced that patient enrollment has been completed in a randomized Phase 2 study of paclitaxel plus REOLYSIN(®) versus paclitaxel alone in patients with persistent or recurrent ovarian, fallopian tube or primary peritoneal cancer (GOG186H). The study chair is David E. Cohn, MD, gynecologic oncology division director at The Ohio State University Comprehensive Cancer Center -...

2014-09-02 08:30:27

SEATTLE, Sept. 2, 2014 /PRNewswire/ -- VentiRx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company committed to the development and commercialization of novel Toll-like receptor 8 (TLR8) immunotherapies, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the investigation of motolimod (VTX-2337) when administered in combination with pegylated liposomal doxorubicin (PLD) for the treatment of women with ovarian cancer...

2014-09-02 08:26:18

PHILADELPHIA, Sept. 2, 2014 /PRNewswire/ -- The Sandy Rollman Ovarian Cancer Foundation (SROCF) will mark National Ovarian Cancer Awareness Month in September with its annual "Get Real With Teal" campaign. http://photos.prnewswire.com/prnvar/20140828/141155 Throughout the month, several iconic buildings in the Greater Philadelphia region including Boat House Row, the National Constitution Center, JFK Plaza Fountain, One Liberty Place and 777 Broad Street, will be illuminated in...

2014-08-26 23:06:37

According to statistics provided by the National Ovarian Cancer Coalition (NOCC), more than 20,000 women are diagnosed with ovarian cancer each year; if caught early enough, the disease is 90% treatable. Lerner and Rowe Injury Attorneys is pleased to give back and help NOCC - Valley of the Sun Chapter Break the Silence on Ovarian Cancer for the 3rd year in a row. Tempe, Arizona (PRWEB) August 26, 2014 Lerner and Rowe Injury Attorneys announce sponsorship of the National Ovarian Cancer...

2014-08-21 23:15:37

Drake University’s Phi Gamma Delta (FIJI) and Colleen’s Dream Foundation have donated $10,000 to support ovarian cancer research conducted by Michael Goodheart, MD, Assistant Professor, Division of Gynecologic Oncology at the University of Iowa’s Holden Comprehensive Cancer Center Holden Cancer Center. Phoenix, AZ (PRWEB) August 21, 2014 Drake University’s Phi Gamma Delta (FIJI) and Colleen’s Dream Foundation have donated $10,000 to support ovarian cancer research, according to...


Latest ovarian cancer Reference Libraries

Ovaries
2013-03-05 14:55:04

The ovaries are the two reproductive female organs where the eggs are produced. These are parallel to the testes in men. Formation and Orientation Each ovary is the size of an almond and is located on one side of the pelvis before the ureter and internal iliac artery but after the external iliac artery. They are attached to either side of the uterus. They are connected and release eggs to fallopian tubes, though not attached, monthly during the menstrual cycle. They also produce...

More Articles (1 articles) »
Word of the Day
conjunto
  • A style of popular dance music originating along the border between Texas and Mexico, characterized by the use of accordion, drums, and 12-string bass guitar and traditionally based on polka, waltz, and bolero rhythms.
The word 'conjunto' comes through Spanish, from Latin coniūnctus, past participle of coniungere, to join together; see conjoin